financetom
Business
financetom
/
Business
/
Update: Warner Bros. Discovery Reportedly Sues NBA After TV Rights Go to Rivals
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Warner Bros. Discovery Reportedly Sues NBA After TV Rights Go to Rivals
Jul 26, 2024 10:29 AM

01:04 PM EDT, 07/26/2024 (MT Newswires) -- (Updates to reflect Warner and the NBA did not immediately respond to requests for comment.)

Warner Bros. Discovery ( WBD ) has filed a lawsuit against the National Basketball Association in a New York state court after the league awarded the TV rights to its rivals, according to media reports Friday.

Several news outlets reported Wednesday the NBA has turned down an offer from Warner Bros. Discovery ( WBD )-owned TNT Sports because it did not meet the terms of the offer from Amazon.com's ( AMZN ) Amazon Prime Video.

The NBA said late Wednesday it has renewed its partnership with Walt Disney ( DIS ) and signed new agreements with Comcast ( CMCSA )-owned (CMCSA) NBCUniversal, in addition to Amazon ( AMZN ).

Warner Bros. and the NBA did not immediately respond to requests for comment from MT Newswires.

Price: 8.19, Change: +0.20, Percent Change: +2.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GSK Invests in BioVersys to Speed Development of Potential Tuberculosis Treatment
GSK Invests in BioVersys to Speed Development of Potential Tuberculosis Treatment
May 7, 2024
05:51 AM EDT, 05/07/2024 (MT Newswires) -- GSK (GSK) and BioVersys have expanded their collaboration to speed up development of alpibectir, a potential tuberculosis treatment, BioVersys said Tuesday. As part of the deal, GSK will take a 12.3 million Swiss franc ($13.5 million) stake in BioVersys in the latter's latest investment round. GSK and BioVersys will collaborate beyond an ongoing...
UBS CEO says job cuts in Switzerland to start in late 2024
UBS CEO says job cuts in Switzerland to start in late 2024
May 7, 2024
ZURICH (Reuters) - UBS's CEO on Tuesday said the majority of job cuts in its home market, Switzerland, will start from around the end of the year and continue into 2025 and 2026. In a call with journalists, Sergio Ermotti said the cuts are not something the bank sees as imminent and that in the next months it will need...
Macron seeks to charm Xi into trade concessions in Pyrenees jaunt
Macron seeks to charm Xi into trade concessions in Pyrenees jaunt
May 7, 2024
TARBES, France, May 7 (Reuters) - French President Emmanuel Macron welcomes Chinese President Xi Jinping in the Pyrenees mountains on Tuesday, for the second day of a trip during which Xi showed little sign of being ready to offer major concessions on trade or foreign policy. Macron, who will greet Xi at the Tarbes-Lourdes Pyrenees airport at around 11:40 a.m....
Helius Medical Technologies Prices $6.4 Million Public Offering
Helius Medical Technologies Prices $6.4 Million Public Offering
May 7, 2024
05:46 AM EDT, 05/07/2024 (MT Newswires) -- Helius Medical Technologies ( HSDT ) said Monday it priced a public offering of 804,999 class A common shares and about 2 million pre-funded warrants, each to buy one common share together with accompanying series A and series B warrants to buy up to about 5.7 million common shares. The price of each...
Copyright 2023-2026 - www.financetom.com All Rights Reserved